Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX
· Real-Time Price · USD
0.80
0.00 (0.13%)
At close: Aug 15, 2025, 3:59 PM
0.82
2.50%
Pre-market: Aug 18, 2025, 08:00 AM EDT
Lexaria Bioscience Balance Sheet Statement
Financials in USD. Fiscal
year is
September - August.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 |
Cash & Equivalents | 4.59M | 6.47M | 8.08M | 6.5M | 8.46M | 4.71M | 1.95M | 1.35M | 3.16M | 3.27M | 4.53M | 5.81M | 7.05M | 8.36M | 9.68M | 10.92M | 8.11M | 9.35M | 525.34K |
Short-Term Investments | 33.54K | 73.92K | 39.88K | 55.81K | 46.31K | 87.7K | 72.43K | 125.64K | 269.56K | 267.7K | 269.71K | 347.33K | 288.03K | 552.32K | 493.42K | 833.84K | 400.74K | 470.63K | 43.73K |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 39.49K | 48.56K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 394.48K | n/a |
Other Long-Term Assets | 64.01K | 64.01K | 64.01K | 63.58K | 63.58K | 39.49K | -884.58K | -884.21K | -1M | n/a | -854.11K | -856.41K | n/a | n/a | n/a | n/a | n/a | 394.48K | n/a |
Receivables | 358.13K | 331.17K | 263.49K | 154.48K | 208.44K | 357.09K | 534.73K | 175.25K | 172.28K | 86.18K | 286.32K | 201.78K | 154.87K | 506.62K | 461.51K | 342.4K | 954.1K | 627.78K | 427.33K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.59K | 9.94K | 38.42K | 40.18K | 31.93K | 26.97K | 29.65K | 51.74K | 137.28K | 125.96K |
Other Current Assets | n/a | n/a | 444.12K | n/a | n/a | n/a | n/a | n/a | n/a | 50.61K | n/a | n/a | n/a | n/a | n/a | n/a | 30.00 | n/a | 49.33K |
Total Current Assets | 5.81M | 7.72M | 8.83M | 7.9M | 9.09M | 5.42M | 2.69M | 2.2M | 4.24M | 4M | 5.36M | 6.98M | 8.29M | 10.57M | 10.9M | 12.44M | 9.69M | 10.95M | 1.31M |
Property-Plant & Equipment | 354.15K | 358.33K | 398.65K | 389.55K | 362.61K | 376.31K | 390.2K | 421.59K | 455.02K | 333.47K | 353.56K | 367.95K | 405.79K | 430.91K | 465.8K | 459.25K | 495.65K | 532.51K | 570.55K |
Goodwill & Intangibles | 516.42K | 506.18K | 505.37K | 516.68K | 498.88K | 519.25K | 494.38K | 462.63K | 549.12K | 517.73K | 500.55K | 488.46K | 440.68K | 411.45K | 378.75K | 364.62K | 366.34K | 299.05K | 296.06K |
Total Long-Term Assets | 934.59K | 928.52K | 968.03K | 969.8K | 925.06K | 935.06K | 933.14K | 884.21K | 1M | 851.2K | 854.11K | 856.41K | 846.47K | 842.36K | 844.55K | 823.88K | 861.99K | 1.23M | 866.61K |
Total Assets | 6.74M | 8.68M | 9.79M | 8.87M | 10.02M | 6.35M | 3.63M | 3.08M | 5.24M | 4.85M | 6.21M | 7.83M | 9.14M | 11.41M | 11.75M | 13.27M | 10.55M | 12.17M | 2.17M |
Account Payables | 1.45M | 1.28M | 262.09K | 1.06M | 121.31K | 47.66K | 92.13K | 225.04K | 985.08K | 180.12K | 162.67K | 25.85K | 90.05K | 60.87K | 172.88K | 59.89K | 163.75K | 134.63K | 12.66K |
Deferred Revenue | n/a | n/a | n/a | 4.96K | n/a | n/a | n/a | n/a | n/a | 4.28K | n/a | n/a | n/a | n/a | 9.05K | 45K | 5.39K | 1K | 35.5K |
Short-Term Debt | n/a | n/a | 28.81K | n/a | n/a | 26.4K | n/a | n/a | n/a | n/a | n/a | 42.59K | 7.91K | 7.88K | 7.82K | 7.93K | 7.51K | 7.51K | n/a |
Other Current Liabilities | n/a | 514.42K | n/a | n/a | n/a | -18.74K | n/a | n/a | n/a | n/a | n/a | 51.71K | -8.25K | n/a | 1.05K | 46.05K | 11.47K | 218.67K | 157.62K |
Total Current Liabilities | 1.49M | 1.82M | 297.8K | 1.1M | 156.05K | 81.72K | 124.52K | 267.74K | 1.06M | 223.13K | 281.52K | 194.04K | 206.83K | 165.54K | 237.7K | 153.28K | 221.22K | 399.39K | 242.47K |
Long-Term Debt | n/a | n/a | 101.92K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30.85K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 86.71K | 94.39K | 101.92K | 109.32K | 115.33K | 122.49K | 129.52K | 136.17K | 142.59K | n/a | 270.51K | 7.4K | 18.34K | 29.08K | 39.63K | 49.99K | 60.16K | 70.16K | 110.82K |
Total Liabilities | 1.57M | 1.92M | 399.72K | 1.21M | 271.38K | 204.2K | 254.04K | 403.91K | 1.2M | 223.13K | 281.52K | 201.44K | 225.16K | 194.62K | 277.33K | 203.26K | 281.38K | 469.55K | 353.3K |
Total Debt | 116.59K | 123.72K | 130.73K | 137.37K | 142.59K | 148.88K | 155.07K | 163.97K | 174.9K | 29.08K | 39.63K | 49.99K | 68.07K | 78.03K | 87.79K | 97.32K | 106.16K | 115.25K | 147.52K |
Common Stock | 19.56K | n/a | n/a | 15.81K | 15.81K | 12.39K | 10.31K | 8.09K | 8.09K | 5.95K | 5.95K | 5.95K | 5.95K | 5.95K | 5.73K | 5.73K | 5.1K | 5.1K | 3K |
Retained Earnings | -60.76M | -56.98M | -54.26M | -51.56M | -49.37M | -47.59M | -46.94M | -45.76M | -44.52M | -42.15M | -40.85M | -39.1M | -37.63M | -35.25M | -33.82M | -31.83M | -30.65M | -28.09M | -28.5M |
Comprehensive Income | -81.07K | -118.25K | -22.99K | -19.82K | -21.87K | -20.63K | 4.37K | n/a | n/a | n/a | 0.00 | 0.00 | n/a | n/a | n/a | -0.00 | 0.00 | n/a | n/a |
Shareholders Equity | 5.55M | 7.14M | 9.77M | 8.04M | 10.12M | 6.52M | 3.74M | 3.04M | 4.4M | 4.97M | 6.26M | 7.95M | 9.18M | 11.46M | 11.68M | 13.27M | 10.34M | 11.77M | 1.88M |
Total Investments | 33.54K | 73.92K | 39.88K | 55.81K | 46.31K | 127.19K | 72.43K | 125.64K | 269.56K | 267.7K | 269.71K | 347.33K | 288.03K | 552.32K | 493.42K | 833.84K | 400.74K | 470.63K | 43.73K |